tirzepatide being banned has been officially removed from the FDA shortage list FDA Bans Compounded Tirzepatide! What

The normalization of intestinal permeability, while not formally included among STRIDE-II targets, represents a desirable future endpoint that may further refine the assessment of barrier restoration

However, little research has been undertaken to quantify the location and amount of drug antigen generated, with virtually no studies looking at skin resident bioactivation of drugs in vivo

Mild changes in urinary frequency often dont get coded as adverse events unless theyre disruptive

Confusion around how GLP-1s work remains common Nearly 3 in 10 Americans (29%) cannot accurately explain how GLP-1 medications work

Because of its effectiveness, demand for Wegovy continues to grow

But the marketing will matter